Associations between DRDs and schizophrenia in a Korean population: Multi-stage association analyses

Experimental and Molecular Medicine

Volumn 43, Issue 1, 2011, Pages 44-52

  Lee, Kyu Young ^a   Joo, Eun Jeong ^a   Ji, Yong Ick ^b   Kim, Duk Hwan ^b,c   Park, Joobae ^b,c   Chung, In Won ^d   Lee, Sang Ick ^e   Joo, Yeon Ho ^f   Ahn, Yong Min ^g   Song, Joo Yun ^g   Kim, Yong Sik ^g  

^a Eulji General Hospital   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Dongguk University Ilsan Hospital   (South Korea)

^e Chungbuk National University   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Seoul National University College of Medicine   (South Korea)

Author keywords

Asian continental ancestry group; Dopamine; Gene pool; Genetic association studies; Receptors; Schizophrenia

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KOREA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79251640193     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2011.43.1.005     Document Type: Article

References (57)

1. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van HR, Gorman JM, Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 2002;22: 3708-19.
2. Abi-Dargham A, Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 2003;9:404-16.
3. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. Systematic metaanalyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008; 40:827-34.
4. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997;6:577-82.
5. Bellgrove MA, Hawi Z, Lowe N, Kirley A, Robertson IH, Gill M. DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and -521 SNP. Am J Med Genet B Neuropsychiatr Genet 2005;136B:81-6.
6. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrixassisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 2001;98:581-4.
7. Chowdari KV, Northup A, Pless L, Wood J, Joo YH, Mirnics K, Lewis DA, Levitt PR, Bacanu SA, Nimgaonkar VL. DNA pooling: a comprehensive, multi-stage association analysis of ACSL6 and SIRT5 polymorphisms in schizophrenia. Genes Brain Behav 2007;6:229-39.
8. Cichon S, Nothen MM, Rietschel M, Korner J, Propping P. Single-strand conformation analysis (SSCA) of the dopamine D1 receptor gene (DRD1) reveals no significant mutation in patients with schizophrenia and manic depression. Biol Psychiatry 1994;36:850-3.
9. Di Forti M, Lappin JM, Murray RM. Risk factors for schizophrenia-- all roads lead to dopamine. Eur Neuropsychopharmacol 2007;17(Suppl 2):S101-7.
10. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, Czerski PM, Leszczynska-Rodziewicz A, Kapelski P, Kaczmarkiewicz-Fass M, Hauser J. Dopamine receptor D1 gene-48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology 2006;53:46-50.
11. Dubertret C, Gorwood P, Ades J, Feingold J, Schartz JC, Sokoloff P. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. Am J Med Genet 1998;81:318-22.
12. Escamilla MA, Ontiveros A, Nicolini H, Raventos H, Mendoza R, Medina R, Munoz R, Levinson D, Peralta JM, Dassori A, Almasy L. A genome-wide scan for schizophrenia and psychosis susceptibility loci in families of Mexican and Central American ancestry. Am J Med Genet B Neuropsychiatr Genet 2007;144B:193-9.
13. Glatt SJ, Faraone SV, Tsuang MT. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 2003;8:911-5.
14. Grandy DK, Zhou QY, Allen L, Litt R, Magenis RE, Civelli O, Litt M. A human D1 dopamine receptor gene is located on chromosome 5 at q35.1 and identifies an EcoRI RFLP. Am J Hum Genet 1990;47:828-34.
15. Gunnell D, Lewis S, Wilkinson J, Georgieva L, Davey GS, Day IN, Holly JM, O'Donovan MC, Owen MJ, Kirov G, Zammit S. IGF1, growth pathway polymorphisms and schizophrenia: a pooling study. Am J Med Genet B Neuropsychiatr Genet 2007;144B:117-20.
16. Hill SK, Harris MS, Herbener ES, Pavuluri M, Sweeney JA. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Schizophr Bull 2008;34:743-59.
17. Hoenicka J, Garrido E, Ponce G, Rodríguez-Jiménez R, Martínez I, Rubio G, Jiménez-Arriero MA, Palomo T. Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2010;153B:948-54.
18. Hong JM, Kim TH, Kim HJ, Park EK, Yang EK, Kim SY. Genetic association of angiogenesis-and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head. Exp Mol Med 2010;42:376-85.
19. Hoogendoorn ML, Bakker SC, Schnack HG, Selten JP, Otten HG, Verduijn W, van der Heijden FM, Pearson PL, Kahn RS, Sinke RJ. No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. Am J Med Genet B Neuropsychiatr Genet 2005;134B:6-9.
20. Jonsson EG, Sedvall GC, Nothen MM, Cichon S. Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses. Schizophr Res 2003;61:111-9.
21. Joo EJ, Joo YH, Hong JP, Hwang S, Maeng SJ, Han JH, Yang BH, Lee YS, Kim YS. Korean version of the diagnostic interview for genetic studies: validity and reliability. Compr Psychiatry 2004;45:225-9.
22. Joyce PR, Rogers GR, Miller AL, Mulder RT, Luty SE, Kennedy MA. Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders. Psychiatry Res 2003;119:1-10.
23. Kamakura S, Iwaki A, Matsumoto M, Fukumaki Y. Cloning and characterization of the 5'-flanking region of the human dopamine D4 receptor gene. Biochem Biophys ResCommun 1997;235:321-6.
24. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 2005;79:59-68.
25. Kirley A, Lowe N, Mullins C, McCarron M, Daly G, Waldman I, Fitzgerald M, Gill M, Hawi Z. Phenotype studies of the DRD4 gene polymorphisms in ADHD: association with oppositional defiant disorder and positive family history. Am J Med Genet B Neuropsychiatr Genet 2004;131B:38-42.
26. Lencz T, Robinson DG, Xu K, Ekholm J, Sevy S, Gunduz-Bruce H, Woerner MG, Kane JM, Goldman D, Malhotra AK. DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry 2006;163:529-31.
27. Liu K, Muse SV. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005;21:2128-9.
28. Liu Q, Sobell JL, Heston LL, Sommer SS. Screening the dopamine D1 receptor gene in 131 schizophrenics and eight alcoholics: identification of polymorphisms but lack of functionally significant sequence changes. Am J Med Genet 1995;60:165-71.
29. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: consensus, uncertainty, and challenges. Nat Rev Genet 2008;9:356-69.
30. McGhee KA, Morris DW, Schwaiger S, Nangle JM, Donohoe G, Clarke S, Meagher D, Quinn J, Scully P, Waddington JL, Gill M, Corvin A. Investigation of the apolipoprotein-L (APOL) gene family and schizophrenia using a novel DNA pooling strategy for public database SNPs. Schizophr Res 2005; 76:231-8.
31. Mitsuyasu H, Hirata N, Sakai Y, Shibata H, Takeda Y, Ninomiya H, Kawasaki H, Tashiro N, Fukumaki Y. Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene (DRD4) with schizophrenia and personality traits. J Hum Genet 2001; 46:26-31.
32. Mohlke KL, Erdos MR, Scott LJ, Fingerlin TE, Jackson AU, Silander K, Hollstein P, Boehnke M, Collins FS. Highthroughput screening for evidence of association by using mass spectrometry genotyping on DNA pools. Proc Natl Acad Sci USA 2002;99:16928-33.
33. Muir W, McKechanie A. Can epigenetics help in the discovery of therapeutics for psychiatric disorders, especially schizophrenia? Expert Opinion on Drug Discovery 2009;4: 621-627.
34. Newton SS, Duman RS. Chromatin remodeling: a novel mechanism of psychotropic drug action. Mol Pharmacol 2006;70:440-3.
35. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994;51:849-59.
36. O'Donovan MC, Craddock NJ, Owen MJ. Genetics ofpsychosis: insights from views cross the genome. Hum Genet 2009;126:3-12.
37. Okubo Y, Suhara T, Sudo Y, Toru M. Possible role of dopamine D1 receptors in schizophrenia. Molecular Psychiatry 1997;2:291-2.
38. Okuyama Y, Ishiguro H, Toru M, Arinami T. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 1999;258:292-5.
39. Okuyama Y, Ishiguro H, Nankai M, Shibuya H, Watanabe A, Arinami T. Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait. Mol Psychiatry 2000;5:64-9.
40. Owen MJ, Williams NM, O'Donovan MC. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 2004;9:14-27.
41. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
42. Rybakowski JK, Borkowska A, Czerski PM, Kapelski P, Dmitrzak-Weglarz M, Hauser J. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J Neural Transm 2005;112:1575-82.
43. Saiz PA, Garcia-Portilla MP, Arango C, Morales B, Arias B, Corcoran P, Fernandez JM, Alvarez V, Coto E, Bascaran MT, Bousono M, Fananas L, Bobes J. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: data from an association study. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:26-31.
44. Schnack HG, Bakker SC, van 't Slot R, Groot BM, Sinke RJ, Kahn RS, Pearson PL. Accurate determination of microsatellite allele frequencies in pooled DNA samples. Eur J Hum Genet 2004;12:925-34.
45. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse 2006; 60:319-46.
46. Sham P, Bader JS, Craig I, O'Donovan M, Owen M. DNA Pooling: a tool for large-scale association studies. Nat Rev Genet 2002;3:862-71.
47. Sklar P, Pato MT, Kirby A, Petryshen TL, Medeiros H, Carvalho C, Macedo A, Dourado A, Coelho I, Valente J, Soares MJ, Ferreira CP, Lei M, Verner A, Hudson TJ, Morley CP, Kennedy JL, Azevedo MH, Lander E, Daly MJ, Pato CN. Genome-wide scan in Portuguese island families identifies5q31-5q35 as a susceptibilty locus for schizophrenia and psychosis. Mol Psychiatry 2004;9:213-8.
48. Srivastava V, Deshpande SN, Thelma BK. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians. Neuropsychobiology 2010;61:64-70.
49. Talkowski ME, Kirov G, Bamne M, Georgieva L, Torres G, Mansour H, Chowdari KV, Milanova V, Wood J, McClain L, Prasad K, Shirts B, Zhang J, O'Donovan MC, Owen MJ, Devlin B, Nimgaonkar VL. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet 2008;17:747-58.
50. Tost H, Alam T, Meyer-Lindenberg A. Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev 2010;34:689-700.
51. Werner M, Sych M, Herbon N, Illig T, Konig IR, Wjst M. Large-scale determination of SNP allele frequencies in DNA pools using MALDI-TOF mass spectrometry. Hum Mutat 2002;20:57-64.
52. Xing Q, Qian X, Li H, Wong S, Wu S, Feng G, Duan S, Xu M, Gao R, Qin W, Gao J, Meng J, He L. The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients. Int J Neuropsychopharmacol 2007;10:631-7.
53. Yang JW, Jang WS, Hong SD, Ji YI, Kim DH, Park J, Kim SW, Joung YS. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention-deficit hyperactivity disorder: evidence of association with the -521 C/T SNP. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:243-8.
54. Zaharieva I, Georgieva L, Nikolov I, Kirov G, Owen MJ, O'Donovan MC, Toncheva D. Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping. BMC Psychiatry 2008;8:11.
55. Zhang AP, Yu J, Liu JX, Zhang HY, Du YY, Zhu JD, He G, Li XW, Gu NF, Feng GY, He L. The DNA methylation profile within the 5'-regulatory region of DRD2 in discordant sib pairs with schizophrenia. Schizophr Res 2007;90:97-103.
56. Zhang C, Fang Y, Xie B, Cheng W, Du Y, Wang D, Yu S. No genetic association between dopamine D1 receptor gene and [early onset] schizophrenia. Psychiatry Res 2010; 177:350-3.
57. Zheng Y, Wang X, Gu N, Feng G, Zou F, Qin W, Zhang J, Lin W, Tao R, Qian X, He L. A two-Stage linkage analysis of Chinese schizophrenia pedigrees in 10 target chromosomes. Biochem Biophys Res Commun 2006;342:1049-57.